TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $392,000 | -43.6% | 3,387 | -51.9% | 0.00% | -100.0% |
| Q1 2018 | $695,000 | -49.3% | 7,043 | -46.2% | 0.00% | 0.0% |
| Q4 2017 | $1,370,000 | -7.1% | 13,084 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,474,000 | +0.5% | 13,084 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,466,000 | -7.6% | 13,084 | -3.8% | 0.00% | 0.0% |
| Q1 2017 | $1,587,000 | +51.4% | 13,606 | +36.6% | 0.00% | +100.0% |
| Q4 2016 | $1,048,000 | +112.6% | 9,957 | +123.1% | 0.00% | 0.0% |
| Q3 2016 | $493,000 | -30.3% | 4,463 | -8.1% | 0.00% | 0.0% |
| Q2 2016 | $707,000 | +22.5% | 4,854 | +20.5% | 0.00% | 0.0% |
| Q1 2016 | $577,000 | – | 4,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |